检索

期
标题
作者
编号 16 (2014)
Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa
Verbovoy A., Sharonova L., Akhmerova R.
PDF
(Rus)
编号 16 (2013)
Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa
Statsenko M., Derevyanchenko M.
PDF
(Rus)
编号 10 (2013)
Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa
Demidova I., Boeva V.
PDF
(Rus)
编号 16 (2012)
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?
Antsiferov M., Galstyan G.
PDF
(Rus)
编号 7 (2012)
DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY?
Antsiferov M., Ametov A., Zilov A., Antsiferov M., Ametov A., Zilov A.
编号 3 (2012)
SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Nikonova T., Nikonova T.
编号 16 (2011)
DIABETON MB IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PREVENTION OF ITS LATE COMPLICATIONS
Kononenko I., Smirnova O., Smirnova O., Kononenko I.
编号 16 (2010)
ASSESSMENT OF EFFICACY OF EDUCATION OF GENERAL PRACTITIONERS BY THE TRAINING PROGRAM FOR MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Yu Mayorov A., Surkova Y., Dedov I., Mayorov A., Surkova E., Dedov I.
编号 16 (2010)
ETIOPTHOGENIC ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF METABOLIC AND VASCULAR DISORDERS IN TYPE 2 DIABETES MELLITUS
Demidova T., Demidova T.
编号 3 (2010)
Innovative approaches to the treatment of type 2 diabetes mellitus: the role of specialized product for enteral nutrition "Glucerna SR"
Sharafetdinov K., Plotnikova O., Sharafetdinov K., Plotnikova O.
卷 29, 编号 4 (2022)
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M., Koteshkova O., Antsiferov M.
PDF
(Rus)
卷 28, 编号 12 (2021)
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
Shorokhova P., Baranov V.
PDF
(Rus)
卷 27, 编号 12 (2020)
Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial
Shkurova N., Baranova N., Fedin A.
PDF
(Rus)
卷 26, 编号 4 (2019)
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
Biryukova E., Solovyova I.
PDF
(Rus)
编号 11 (2018)
Apelin: biological and pathophysiological effects
Dolgikh Y., Verbovoy A.
PDF
(Rus)
编号 5 (2016)
EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Biryukova E.
PDF
(Rus)
编号 17 (2015)
Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike
Demidov N., Zakharova S., Zav'yalov A.
PDF
(Rus)
编号 5 (2014)
VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Abaeva M., Nazhmutdinova P., Ametov A.
PDF
(Rus)
编号 16 (2013)
Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa
Antsiferov M.
PDF
(Rus)
编号 5 (2013)
SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA
Ruyatkina L., Lomova A., Ruyatkin D.
PDF
(Rus)
编号 3 (2012)
HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?
Biryukova E., Antsiferov M., Biryukova Y., Antsiferov M.
编号 3 (2011)
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
Antsiferov M., Antsiferov M.
编号 16 (2010)
POSSIBILITY OF CORRECTION OF OXIDATIVE STRESS IN PATIENTS WITH DIABETES USING DIBICOR
Zanozina O., Zanozina O.
编号 16 (2010)
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M., Zilov A., Antsiferov M., Zilov A.
卷 29, 编号 11/12 (2022)
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
Antsiferov M., Demidov N., Safronova T., Mishra O.
PDF
(Rus)
卷 29, 编号 4 (2022)
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S., Apetova V.
PDF
(Rus)
卷 28, 编号 12 (2021)
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.
PDF
(Rus)
卷 26, 编号 4 (2019)
The place of glyflozins in the management of type 2 diabetes mellitus
Sharonova L., Verbovoy A.
PDF
(Rus)
编号 11 (2018)
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.
PDF
(Rus)
编号 16 (2017)
Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus
Tsvetkova I., Kaukova A., Belyakova N., Vasyutkova O., Konovalova O., Lareva A.
PDF
(Rus)
编号 17 (2015)
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A., Tsanava I., Verbovaya N.
PDF
(Rus)
编号 5 (2014)
UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa
Antsiferov M., Koteshkova O.
PDF
(Rus)
编号 5 (2014)
TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Kudinov V., Nichitenko M., Chesnikova A.
PDF
(Rus)
编号 16 (2013)
Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
Chernikova N., Ametov A., Antsiferov M.
PDF
(Rus)
编号 5 (2013)
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.
PDF
(Rus)
编号 11 (2012)
Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya
Shilov A., Abdullaeva A.
PDF
(Rus)
编号 7 (2012)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antsiferov M.
编号 3 (2012)
SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?
Kononenko I., Smirnova O., Smirnova O., Kononenko I.
编号 16 (2011)
SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Petunina N., Brashchenkova A., Petunina N., Brashcenkova A.
编号 16 (2010)
PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES
Rudakova A., Rudakova A.
卷 28, 编号 12 (2021)
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.
PDF
(Rus)
卷 28, 编号 3 (2021)
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.
PDF
(Rus)
卷 27, 编号 12 (2020)
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.
PDF
(Rus)
卷 26, 编号 4 (2019)
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A., Ostroumova O., Tkacheva O.
PDF
(Rus)
编号 16 (2017)
Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy
Elsukova O., Sobolev A.
PDF
(Rus)
编号 6 (2017)
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M., Turkina S., Tyshchenko I., Fabritskaya S., Poletaeva L.
PDF
(Rus)
编号 5 (2017)
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N., Antsiferov M., Dorofeeva L.
PDF
(Rus)
编号 5 (2016)
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.
PDF
(Rus)
编号 17 (2015)
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Nikitina T., Rodionova A., Kurbatova K., Ionova T.
PDF
(Rus)
编号 5 (2015)
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M., Koteshkova O.
PDF
(Rus)
编号 16 (2014)
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.
PDF
(Rus)
编号 5 (2013)
O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA
Biryukova E.
PDF
(Rus)
编号 3 (2012)
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
编号 5 (2011)
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.
编号 3 (2011)
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Trukhina L., Petunina N., Truhina L.
编号 16 (2010)
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.
编号 8 (2010)
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.
编号 3 (2010)
Advance - movement forward
Petunina N., Petunina N.
卷 30, 编号 12 (2023)
Diabetic neuropathy: pathophysiological mechanisms and metabolic therapy
Kurnikova I.
PDF
(Rus)
卷 29, 编号 4 (2022)
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A., Zhulina Y., Rozhkova V., Martynova E., Poteshkin Y.
PDF
(Rus)
卷 27, 编号 12 (2020)
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T., Fadeyev V.
PDF
(Rus)
卷 26, 编号 14 (2019)
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O., Goloborodova I.
PDF
(Rus)
编号 4 (2018)
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A., Kondrashova O., Chernykh L., Pollyak O., Yusupova A., Slovak M., Zaykova I.
PDF
(Rus)
编号 6 (2017)
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.
PDF
(Rus)
编号 5 (2017)
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y., Veliyeva O.
PDF
(Rus)
编号 16 (2016)
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M., Schernthaner G.
PDF
(Rus)
编号 17 (2015)
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I., Petryaykina E., Koltunov I.
PDF
(Rus)
编号 5 (2015)
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.
PDF
(Rus)
编号 16 (2013)
Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom
Shavlovskaya O.
PDF
(Rus)
编号 16 (2013)
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N., Antsiferov M.
PDF
(Rus)
编号 5 (2013)
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.
PDF
(Rus)
编号 20 (2012)
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L., Sorokin M.
PDF
(Rus)
编号 3 (2012)
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
编号 16 (2011)
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M., Antciferov M.
编号 3 (2011)
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M., Koteshkova O., Kleymenova S., Antsiferov M., Koteshkova O., Kleimenko S.
编号 16 (2010)
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Petunina N.
编号 3 (2010)
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L., Nedosugova L.
101 - 177 的 177 信息 << < 1 2 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##